| Economic burden of nausea and vomiting of pregnancy in the USA. C Piwko, G Koren, V Babashov, C Vicente, TR Einarson Journal of Population Therapeutics and Clinical Pharmacology= Journal de la …, 2013 | 110 | 2013 |
| Reducing patient waiting times for radiation therapy and improving the treatment planning process: a discrete-event simulation model (radiation treatment planning) V Babashov, I Aivas, MA Begen, JQ Cao, G Rodrigues, D D’souza, ... Clinical Oncology 29 (6), 385-391, 2017 | 62 | 2017 |
| Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) for treatment of symptomatic uterine fibroids: an economic analysis V Babashov, S Palimaka, G Blackhouse, D O'Reilly Ontario Health Technology Assessment Series 15 (5), 1, 2015 | 25 | 2015 |
| Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma V Babashov, MA Begen, J Mangel, GS Zaric Current Oncology 24 (1), 6-14, 2017 | 18 | 2017 |
| Framework for drug formulary decision using multiple-criteria decision analysis V Babashov, S Ben Amor, G Reinhardt Medical Decision Making 40 (4), 438-447, 2020 | 4 | 2020 |
| Setting wait time targets in a multi‐priority patient setting V Babashov, A Sauré, O Ozturk, J Patrick Production and Operations Management, 2023 | 1 | 2023 |
| Cost-utility analysis of enzalutamide for patients with previously treated metastatic castration-resistant prostate cancer (MCRPC) C Vicente, V Babashov, F Husein, F Saad, S Naidoo, S Holmstrom Value in Health 17 (3), A89-A90, 2014 | 1 | 2014 |
| Three Practical Problems in Healthcare Analytics V Babashov Université d'Ottawa/University of Ottawa, 2021 | | 2021 |
| Preliminary Economic Evaluation of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: An" Early Look" Model Based on Phase II Results V Babashov The University of Western Ontario (Canada), 2012 | | 2012 |
Gregory ZaricIvey Business School在 ivey.uwo.ca 的电子邮件经过验证
